Updated Results from a Phase I Trial of Amulirafusp Alfa (IMM0306) in Patients with Relapsed or Refractory CD20-Positive B-Cell Non-Hodgkin's Lymphoma
Year: 2024
Type: conference-abstract
Source: Blood
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Zhengzhou University, Henan Cancer Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, First Affiliated Hospital of Zhengzhou University, Peking University, Peking University Third Hospital, Second Affiliated Hospital of Nanchang University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405042368